TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation March 13, 2009
TCL Archive Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve. April 13, 2007